Table 1 Cancer driver genes involved in epigenetics

From: The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

Pathways involved in epigenetics

Driver genes

Tumor suppressor/oncogene prediction (by 20/20+a)

Approved name

Activity

Cancer typeb

Other driver genes in this pathways

Histone modification

KDM6A

tsg

Lysine demethylase 6A, UTX

H3K27me2/3 demethylase

BLCA, HNSC, KIRP, LUSC, PAAD, PANCAN, PRAD

PPP6C

SETD2

tsg

SET domain-containing 2

H3K36 methyl transferase

KIRC, KIRP, LGG, LUAD, MESO, PANCAN

Chromatin histone modifiers

KDM5C

tsg

Lysine demethylase 5C, JARID1C

H3K4me2/3 demethylase

KIRC, PANCAN

ARID5B, CREBBP, EP300, KANSL1, MEN1, NCOR1, NSD1, SIN3A, WHSC1, ZMYM3

KMT2A

tsg

Lysine methyltransferase 2A

H3K4 methyl transferase

PANCAN

KMT2B

tsg

Lysine methyltransferase 2B

H3K4 methyl transferase

PANCAN, UCEC

KMT2C

tsg

Lysine methyltransferase 2C

H3K4 methyl transferase

BLCA, BRCA, CESC, PANCAN, UCEC

KMT2D

tsg

Lysine methyltransferase 2D

H3K4 methyl transferase

BLCA, CESC, DLBC, ESCA, HNSC, LUSC, PANCAN, PRAD

Chromatin (other)

H3F3A

Possible oncogene

H3 histone family member 3A, H3.3A

 

PANCAN

AJUBA, ASXL1, ASXL2, ATF7IP, BCOR, CHD3, CHD4, CHD8, CTCF, NIPBL, NPM1

H3F3C

H3 histone family member 3C, H3.5

 

PANCAN

HIST1H1E

Possible oncogene

HIST1H1E, H1.4

 

DLBC

 

Possible tsg

HIST1H1E, H1.4

 

LIHC

Metabolism

IDH1

Oncogene

Isocitrate dehydrogenase (NADP(+)) 1

NADP-dependent IDH, Cytosolic

CHOL, GBM, LAML, LGG, LIHC, PANCAN, PRAD, SKCM

IDH2

Oncogene

Isocitrate dehydrogenase (NADP(+)) 2

NADP-dependent IDH, Mitochondrial

LAML, LGG, PANCAN

  1. Among the 299 driver genes mentioned by Bailey et al.47, only the epigenetics-related pathways have been sorted out
  2. a20/20+: Classifies genes as an oncogene, tumor suppressor gene, or as a nondriver gene using Random Forests, http://2020plus.readthedocs.org
  3. bBLCA (bladder urothelial carcinoma), BRCA (breast invasive carcinoma), CESC (cervical squamous cell carcinoma and endocervical adenocarcinoma), CHOL (cholangiocarcinoma), DLBC (lymphoid neoplasm diffuse large B-cell lymphoma), ESCA (esophageal carcinoma), GBM (glioblastoma multiforme), HNSC (head and neck squamous cell carcinoma), KIRC (kidney renal clear cell carcinoma), KIRP (kidney renal papillary cell carcinoma), LAML (acute myeloid leukemia), LGG (brain lower grade glioma), LIHC (liver hepatocellular carcinoma), LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), MESO (mesothelioma), PAAD (pancreatic adenocarcinoma), PANCAN (Pan-cancer), PRAD (prostate adenocarcinoma), SKCM (skin cutaneous melanoma), THCA (thyroid carcinoma), UCEC (uterine corpus endometrial carcinoma)